All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-MV-01LX192 | Anti-ANTXR1 (1D2) h(CD28-CD3ζ) CAR, pMMLV | Human | 1D2 | Mouse | scFv-CD28-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX193 | Anti-ANTXR1 (T803) h(CD28-CD3ζ) CAR, pMMLV | Human | T803 | Humanized | scFv-CD28-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-0822-YF14 | Anti-Human ANTXR1 (XW-14) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-14 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF15 | Anti-Human ANTXR1 (XW-15) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-15 | Human | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF934 | Anti-Human ANTXR1 (XW-14) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-14 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF935 | Anti-Human ANTXR1 (XW-15) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-15 | Human | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1854 | Anti-Human ANTXR1 (XW-14) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-14 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1855 | Anti-Human ANTXR1 (XW-15) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-15 | Human | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF8594 | TS-Fluc Anti-Human ANTXR1 scFv (XW-14) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-14 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8595 | TS-Fluc Anti-Human ANTXR1 scFv (XW-15) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-15 | Human | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF9003 | TS-Fluc Anti-Human ANTXR1 scFv (XW-14) 41BB-CD3ζ CAR, pCDCAR1 | Human | XW-14 | Mouse | 7H-YB-Fluc-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF9004 | TS-Fluc Anti-Human ANTXR1 scFv (XW-15) 41BB-CD3ζ CAR, pCDCAR1 | Human | XW-15 | Human | 7H-YB-Fluc-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF9412 | TS-Fluc Anti-Human ANTXR1 scFv (XW-14) CD28-41BB-CD3ζ CAR, pCDCAR1 | Human | XW-14 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF9413 | TS-Fluc Anti-Human ANTXR1 scFv (XW-15) CD28-41BB-CD3ζ CAR, pCDCAR1 | Human | XW-15 | Human | 7H-YB-Fluc-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF9821 | TS-IL15 SA Anti-Human ANTXR1 scFv (XW-14) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-14 | Mouse | 7H-YB-IL15 SA-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF9822 | TS-IL15 SA Anti-Human ANTXR1 scFv (XW-15) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-15 | Human | 7H-YB-IL15 SA-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF10230 | TS-IL15 SA Anti-Human ANTXR1 scFv (XW-14) 41BB-CD3ζ CAR, pCDCAR1 | Human | XW-14 | Mouse | 7H-YB-IL15 SA-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF10231 | TS-IL15 SA Anti-Human ANTXR1 scFv (XW-15) 41BB-CD3ζ CAR, pCDCAR1 | Human | XW-15 | Human | 7H-YB-IL15 SA-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF10639 | TS-IL15 SA Anti-Human ANTXR1 scFv (XW-14) CD28-41BB-CD3ζ CAR, pCDCAR1 | Human | XW-14 | Mouse | 7H-YB-IL15 SA-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF10640 | TS-IL15 SA Anti-Human ANTXR1 scFv (XW-15) CD28-41BB-CD3ζ CAR, pCDCAR1 | Human | XW-15 | Human | 7H-YB-IL15 SA-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION